Press Release 2007

Press Release 2007

According to a recent article in the Economic Times, a leading business-focused newspaper in India, the price of black pepper is predicted to rise in 2007 due to a continued increase in demand coupled with a tight global supply. Production of black pepper by exporting countries including Vietnam and Brazil is down significantly due to drought and India is also predicting below average output of the crop. Black pepper is a commonly used spice and extract of the black pepper fruit (as BioPerine® from Sabinsa Corporation) is used regularly in dietary supplements to enhance the bioavailability of nutrients.

"This decrease in black pepper production will in no way impact our ability to supply customers with our clinically researched, patented BioPerine ingredient," stated Todd Norton, president, Sabinsa Corporation. "However, we anticipate a price increase per kilo of approximately 8 to 10 percent."

BioPerine is a standardized piperine composition derived from black pepper extract that has been shown in clinical research to increase the absorption of nutrients in nutritional supplement formulations. BioPerine and its use are protected under U.S. Patent Nos. 5,536,506, 5,744,161, 5,972,382, and 6,054,585; European Patent No. EP0810868; and International Patents pending.

 

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.